铁和动脉样硬化:从子身上学到的教训与人类疾病相关
Barry Halliwell1, Frank Watt2, Ren Minqin2
1Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Neurobiology Research Programme, National University of Singapore, Centre for Life Sciences, #05-01A, 28 Medical Drive, 117456, Singapore.
Free radical biology & medicine
|October 18, 2023
概括
铁的积累有助于动脉样硬化,这种疾病与心血管和神经退行性疾病有关. 对新西兰白的研究表明,铁促进动脉样硬化,为疾病机制提供了洞察力.
科学领域:
- 心血管科学 心血管科学
- 代谢性疾病研究研究
- 铁的新陈代谢 铁的新陈代谢
背景情况:
- 动脉样硬化是一种复杂的疾病,与心血管和神经退行性疾病有关.
- 铁在动脉样硬化病原体中的作用仍然存在争议.
- 现有的研究主要利用转基因动物模型,如阿波利波蛋白E-Knockout (apoE-/-) 小鼠.
研究的目的:
- 通过使用非转基因动物模型审查铁在动脉样硬化中的作用的研究.
- 为了研究新西兰白 (NZW) 子模型,为动脉样硬化研究食高胆固醇饮食.
- 为了将新西兰新西兰子模型与apoE-/-小鼠模型对人类动脉样硬化相关性进行比较.
主要方法:
- 综述了涉及新西兰白的研究,这些白被养高胆固醇饮食.
- 在这种特定的动物模型中分析动脉样硬化研究的发现.
- 与apoE-/-小鼠研究的现有文献进行比较.
主要成果:
- 对新西兰新西兰子的研究支持铁能促进动脉样硬化发展的假设.
- 虽然新西兰新西兰子模型研究较少,但它可能比人类动脉样硬化的转基因模型有优势.
- 关于铁的确切作用仍然存在一些不确定性,需要进一步调查.
结论:
- 铁对动脉样硬化的贡献得到了新西兰新西兰子模型的证据的支持.
- 新西兰新西兰子模型为研究动脉样硬化和铁的作用提供了一个有价值的替代方案.
- 需要进一步的研究,以充分阐明机制,并解决剩余的问题.
相关概念视频
01:30Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
01:26Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
11
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
01:30Coronary Artery Disease I: Introduction
17
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
01:26Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12